QCI Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-181
Closed -$16K 325
2020
Q1
$16K Buy
181
+35
+24% +$3.72K ﹤0.01% 358
2019
Q4
$17K Sell
146
-176
-55% -$19.3K ﹤0.01% 383
2019
Q3
$35K Buy
322
+176
+121% +$18.4K ﹤0.01% 301
2019
Q2
$14K Sell
146
-85
-37% -$7.76K ﹤0.01% 414
2019
Q1
$21K Buy
231
+125
+118% +$11.2K ﹤0.01% 365
2018
Q4
$10K Buy
106
+85
+405% +$7.94K ﹤0.01% 433
2018
Q3
$2K Hold
21
﹤0.01% 556
2018
Q2
$2K Buy
+21
New +$1.75K ﹤0.01% 527
2017
Q2
Sell
-160
Closed -$13K 670
2017
Q1
$13K Buy
+160
New +$12.5K ﹤0.01% 367
2014
Q1
Sell
-20
Closed -$1K 522
2013
Q4
$1K Sell
20
-50
-71% -$2.83K ﹤0.01% 517
2013
Q3
$4K Buy
70
+50
+250% +$2.69K ﹤0.01% 416
2013
Q2
$1K Buy
+20
New +$989 ﹤0.01% 473

Other funds holding MDT

QCI Asset Management's MDT Position: Q2 2020 in Review

QCI Asset Management sold out of Medtronic (MDT) in Q2 2020, closing a stake of 181 shares — an estimated $16K sold.

QCI Asset Management first reported a position in MDT in Q2 2013 and held it in 12 quarters. The position peaked at $35K in Q3 2019. 1,759 funds tracked by Wall St. Rank hold MDT as of Q2 2020.

  • QCI Asset Management reported no remaining Medtronic position as of Q2 2020 after selling out during the quarter.
  • QCI Asset Management sold 181 Medtronic shares in Q2 2020, an estimated $16K.
  • QCI Asset Management first reported a position in Medtronic in Q2 2013 and held it in 12 quarters.
  • QCI Asset Management's Medtronic position peaked at $35K in Q3 2019.
  • 1,759 funds tracked by Wall St. Rank held Medtronic as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.